J.P. Morgan sells approximately 8.21 million shares of Weichai Power (02338) at an average price of approximately HK$26.67 per share.
On February 6, JPMorgan Chase reduced its holdings of Weichai Power (02338) by 8,214,741 shares, with an average price of 26.6735 Hong Kong dollars per share, totaling approximately 219 million Hong Kong dollars.
The latest data from the Hong Kong Stock Exchange shows that on February 6, J.P. Morgan reduced its holdings of Weichai Power (02338) by 821,474.1 million shares, with an average price of HKD 26.6735 per share, totaling approximately HKD 219 million. After the reduction, the latest number of shares held is approximately 155 million, with a shareholding percentage of 7.98%.
Related Articles

CSPC Innovation Pharmaceutical (300765.SZ) subsidiary SYS6023 antibody-drug conjugate obtains approval for clinical trials.

SINOPEC KANTONS (00934) signs exclusive operating agreement with Caofeidian Port Group.

NOAH HOLDINGS (06686) spent $83,900 to repurchase 35,000 shares on February 11th.
CSPC Innovation Pharmaceutical (300765.SZ) subsidiary SYS6023 antibody-drug conjugate obtains approval for clinical trials.

SINOPEC KANTONS (00934) signs exclusive operating agreement with Caofeidian Port Group.

NOAH HOLDINGS (06686) spent $83,900 to repurchase 35,000 shares on February 11th.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


